Progress in application of phage therapy in diseases

FU Xiaomei1, WANG Yue1, CHEN Qian1, GUO Xiaokui2, LIU Chang1

Journal of Microbes and Infections ›› 2021, Vol. 16 ›› Issue (6) : 417-424.

PDF(764 KB)
Welcome to visit Journal of Microbes and Infections, April 3, 2025
PDF(764 KB)
Journal of Microbes and Infections ›› 2021, Vol. 16 ›› Issue (6) : 417-424. DOI: 10.3969/j.issn.1673-6184.2021.06.008
Review

Progress in application of phage therapy in diseases

  • FU Xiaomei1, WANG Yue1, CHEN Qian1, GUO Xiaokui2, LIU Chang1
Author information +
History +

Abstract

With the worldwide spread of antimicrobial-resistant bacteria, phage therapy has attracted renewed attention as an effective alternative to antibiotics. On the other hand, with the development of research on the interactions between human microbiota and the host, a number of studies have focused on regulating the microbiota to affect human health. The use of phages to reduce the abundance of characteristic bacteria positively associated with disease progression has become a more precise prevention or adjuvant treatment strategy for non-infectious diseases such as cancer, alcoholic liver disease and diabetes. In this paper, the progress of phage therapy applications in infectious and non-infectious diseases was reviewed.

Key words

Human microbiota / Phage / Phage therapy

Cite this article

Download Citations
FU Xiaomei1, WANG Yue1, CHEN Qian1, GUO Xiaokui2, LIU Chang1. Progress in application of phage therapy in diseases[J]. Journal of Microbes and Infections. 2021, 16(6): 417-424 https://doi.org/10.3969/j.issn.1673-6184.2021.06.008

References

 

Funding

 
PDF(764 KB)

Accesses

Citation

Detail

Sections
Recommended

/